Back to search

Article

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

2021-05-11

Abstract excerpt

Molnupiravir is an orally available antiviral drug candidate that is in phase III trials for the treatment of COVID-19 patients 1,2 . Molnupiravir increases the frequency of viral RNA mutations 3,4 and impairs SARS-CoV-2 replication in animal models 4-6 and in patients 2 . Here we establish the molecular mechanisms that underlie molnupiravir-induced RNA mutagenesis by the RNA-dependent RNA polymerase (RdRp) of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2227dd4e-8ec5-5c43-b068-ebb74c1c7092
DOI
10.1101/2021.05.11.443555
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesisDOI 10.1101/2021.05.11.443555
Select a neighboring publication to make it the new centre.